PMA device
TECNIS Multifocal 3-Piece IOL
Johnson & Johnson Surgical Vision, Inc. · Lens, Multifocal Intraocular (MFK, Class III) · First FDA decision Jan 16, 2009, newest Sep 10, 2025Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
104
Naming "TECNIS"
MAUDE reports
0
Brand "TECNIS", since 2015
PubMed studies
686
Mentioning "TECNIS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TECNIS Multifocal 3-Piece IOL
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TECNIS", any status and sponsor, newest update first.
- Contralateral Claims Study of Clareon Vivity ProPivotal-lookingActive, not recruiting
Alcon ResearchNot on our public-company list
NCT07484191 · 165 participants · Start Apr 28, 2026 · Primary completion Oct 28, 2026
Device: Clareon Vivity Pro IOL; Clareon Vivity IOL and 1 more · For: Aphakia; Presbyopia
Sites: Campsie, Australia; Sydney, Australia; Wollongong, Australia · 7 sites in all
- PureSee EDOF Versus ZCB00 Monofocal IOLs in Mild-to-Moderate GlaucomaNot yet recruiting
Mann Eye InstituteAcademic, hospital or other
NCT07924215 · 100 participants (planned) · Start Dec 2, 2026 · Primary completion Oct 29, 2027
Device: TECNIS PureSee Intraocular Lens; TECNIS ZCB00 Monofocal Intraocular Lens · For: Primary Open-Angle Glaucoma
Sites: Houston, Texas
- PureSee/Odyssey Mix-and-Match IOLNot yet recruiting
Gainesville Eye AssociatesAcademic, hospital or other
NCT07898917 · 40 participants (planned) · Start Nov 2026 · Primary completion Dec 2026
Device: Mix-and-match PureSee/Odyssey cohort · For: Cataract
Sites: Gainesville, Georgia
101 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TECNIS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MFK
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TECNIS"[tiab]. The summary above synthesizes these.
- Use of Spectacles after Cataract Surgery.
Tinner C, Eppenberger L, Golla K, et al. · Klin Monbl Augenheilkd · 2023Observational Study
- Quality of vision clinical outcomes for a new fully-refractive extended depth of focus Intraocular Lens.
Corbett D, Black D, Roberts TV, et al. · Eye (Lond) · 2024Randomized Controlled Trial, Multicenter Study
- Optical Bench Evaluation of the Latest Refractive Enhanced Depth of Focus Intraocular Lens.
Schmid R, Borkenstein AF · Clin Ophthalmol · 2024
- Visual performance of the Tecnis one-piece lens ZCB00.
Wahba SS, Riad RF, Morkos FF, et al. · Clin Ophthalmol · 2011
- Optical and clinical simulated performance of a new refractive extended depth of focus intraocular lens.
Alarcon A, Del Aguila Carrasco A, Gounou F, et al. · Eye (Lond) · 2024Research Support, Non-U.S. Gov't
- Chromatic aberration and spectral dependency of extended-range-of-vision intraocular lens technology.
abuz G, Yan W, Baur ID, et al. · Sci Rep · 2023Research Support, Non-U.S. Gov't
- Wavefront-customized intraocular lenses.
Altmann GE · Curr Opin Ophthalmol · 2004Review
- Evaluation of intraocular lens mechanical stability.
Lane S, Collins S, Das KK, et al. · J Cataract Refract Surg · 2019Comparative Study, Research Support, Non-U.S. Gov't
- Multifocal intraocular lens implantation in children with unilateral congenital cataracts.
Jiang M, Zhang J, Ding Y, et al. · J Cataract Refract Surg · 2024Research Support, Non-U.S. Gov't
- Real world outcomes of the new Tecnis Eyhance IOL.
Gigon E, Bouthour W, Panos GD, et al. · Eur J Ophthalmol · 2023
- Optical and Visual Outcomes of a New Refractive Extended Depth of Focus Intraocular Lens.
Alfonso-Bartolozzi B, Martinez-Alberquilla I, Fernández-Vega-Cueto L, et al. · J Refract Surg · 2025
- Comparative clinical outcomes of Tecnis toric IOL implantation in femtosecond laser-assisted cataract surgery and conventional phacoemulsification surgery.
Lai KR, Zhang XB, Yu YH, et al. · Int J Ophthalmol · 2020
Other devices of this type
Also filed under product code MFK.
- AcrySof IQ ReSTOR Posterior Chamber Intraocular LensesAlcon Research, Ltd. · PMA 2025
- SBL-3 Multifocal Intraocular LensLenstec, Inc. · PMA 2022
- ClearView 3Lenstec, Inc. · PMA 2025
- Acrysof Restor Apodized Diffractive IolsAlcon Research, Ltd. · PMA 2013
- Array Multifocal Posterior Chamber Intraocular LensJohnson & Johnson Surgical Vision, Inc. · PMA 2005
- ClearView HD intraocular lens (IOL)Lenstec, Inc. · PMA 2026
- RayOne GalaxyRayner Intraocular Lenses , Ltd. · PMA 2026
- enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)Bausch & Lomb, Inc. · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.